Israeli Companies Face IPO Challenges as Wall Street Focuses on Mega AI Firms

Wall Street stock indices are reaching record highs, driven largely by the artificial intelligence (AI) revolution, with Nvidia becoming a dominant name among investors. However, beneath the surface, the financial landscape is shifting: the IPO window for companies valued in the low billions is nearly closed, placing Israeli firms at a critical crossroads. Ilan Paz, CEO of Barclays Investment Bank Israel, explains that while the US economy remains robust with strong consumer spending and healthy corporate cash flows, the market's attention is fixated on mega-cap companies like SpaceX, Anthropic, and OpenAI, which attract massive private funding and dominate investor interest.

This focus on mega companies has raised the benchmark for public offerings, effectively sidelining smaller firms. Paz categorizes companies into three groups: those with over $500 million in annual revenue and 20% growth have open options including IPOs and M&A; those approaching this scale are advised to remain private until they cross the threshold; and smaller companies that once aimed for IPOs at $100-200 million revenues now face a distant public market and should consider alternative liquidity strategies such as mergers or listings on the Tel Aviv Stock Exchange (TASE).

Barclays recently obtained a TASE underwriting license to attract foreign investors to Israeli IPOs, promoting the local exchange as a viable alternative to the US market. Structural reforms at TASE, including adopting a book-building pricing method and shifting trading days to Monday through Friday, have significantly increased foreign trading volumes. Paz warns that companies below the US scale risk losing analyst coverage and investor interest if they pursue premature US IPOs, which can harm their valuation and liquidity.

With the US public market focused on mega firms, many venture capital investors are pushing for M&A transactions to generate liquidity, as IPOs become less accessible. Paz forecasts that, barring exceptions, Israeli companies are unlikely to pursue US IPOs before 2027. He emphasizes that companies and investors are increasingly aware of these market dynamics and prefer to wait or seek secondary private market transactions to meet liquidity needs rather than rushing into public offerings prematurely.